<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Marijuana and related drugs (cannabinoids) have been proposed as treatments for a widening spectrum of medical disorders </plain></SENT>
<SENT sid="1" pm="."><plain>R(+)-[2, 3-dihydro-5-<z:chebi fb="36" ids="29309">methyl</z:chebi>-3-[(morpholinyl)<z:chebi fb="36" ids="29309">methyl</z:chebi>]pyrrolo[1,2,3-de]-1, 4-benzoxazin-yl]-(1-<z:chebi fb="0" ids="51140">naphthalenyl</z:chebi>)methanone mesylate (R(+)-WIN 55212-2), a synthetic cannabinoid <z:chebi fb="4" ids="48705">agonist</z:chebi>, decreased hippocampal <z:hpo ids='HP_0002529'>neuronal loss</z:hpo> after transient global <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> and reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volume after permanent focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> induced by middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> in rats </plain></SENT>
<SENT sid="2" pm="."><plain>The less active enantiomer S(-)-WIN 55212-3 was ineffective, and the protective effect of R(+)-WIN 55212-2 was blocked by the specific central cannabinoid (CB1) cannabinoid receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-4-<z:chebi fb="36" ids="29309">methyl</z:chebi>-1H-<z:chebi fb="0" ids="14973">pyrazole</z:chebi>-3-<z:chebi fb="0" ids="23004,37622">carboxamide</z:chebi>-<z:chebi fb="16" ids="36807">hydrochloride</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>R(+)-WIN 55212-2 also protected cultured cerebral cortical neurons from in vitro <z:mp ids='MP_0005039'>hypoxia</z:mp> and <z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation, but in contrast to the receptor-mediated neuroprotection observed in vivo, this in vitro effect was not stereoselective and was insensitive to CB1 and CB2 receptor <z:chebi fb="68" ids="48706">antagonists</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>Cannabinoids may have therapeutic potential in disorders resulting from <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, including <z:hpo ids='HP_0001297'>stroke</z:hpo>, and may protect neurons from injury through a variety of mechanisms </plain></SENT>
</text></document>